Literature DB >> 27214757

Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.

H J Braun1, E R Perito2,3, J L Dodge4, S Rhee5, J P Roberts4.   

Abstract

Nonstandard exceptions requests (NSERs), in which transplant centers appeal on a case-by-case basis for Pediatric End-Stage Liver Disease/Mayo End-Stage Liver Disease points, have been highly utilized for pediatric liver transplant candidates. We evaluated whether NSE outcomes are associated with waitlist and posttransplant mortality. United Network for Organ Sharing (UNOS) Scientific Registry of Transplant Recipients data on pediatric liver transplant candidates listed in 2009-2014 were analyzed after excluding those granted automatic UNOS exceptions. Of 2581 pediatric waitlist candidates, 44% had an NSE request. Of the 1134 children with NSERs, 93% were approved and 7% were denied. For children 2-18 years at listing, NSER denial increased the risk of waitlist mortality or removal for being too sick (subhazard ratio 2.99, 95% confidence interval [CI] 1.26-7.07, p = 0.01 in multivariate analysis). For children younger than 2 years, NSER denial did not impact waitlist mortality/removal. Children with NSER approved had reduced risk of graft loss 3 years posttransplant in univariate but not multivariable analysis (odds ratio 0.73, 95% CI 0.53-1.01, p = 06). Those with NSER denial had a higher risk of posttransplant death than those with no NSER (hazard ratio 2.43, 95% CI 0.99-5.95, p = 0.05, multivariable analysis), but NSER approval did not impact posttransplant death. Further research on NSER utilization in pediatric liver transplant is needed to optimize organ allocation and outcomes for children. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  United Network for Organ Sharing (UNOS); clinical research/practice; health services and outcomes research; liver transplantation/hepatology; organ allocation; patient survival; pediatrics; waitlist management

Mesh:

Year:  2016        PMID: 27214757      PMCID: PMC5083236          DOI: 10.1111/ajt.13879

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Organ Procurement and Transplantation Network. Health Resources and Services Administration, HHS. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1999-10-20

2.  The HMS Birkenhead docks in Brazil: pediatric end-stage liver disease times three.

Authors:  Benjamin L Shneider; Mark S Roberts; Kyle Soltys
Journal:  Liver Transpl       Date:  2010-04       Impact factor: 5.799

3.  Patient, center and geographic characteristics of nationally placed livers.

Authors:  J C Lai; J P Roberts; E Vittinghoff; N A Terrault; S Feng
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

4.  Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure.

Authors:  Renata Pugliese; Eduardo A Fonseca; Gilda Porta; Vera Danesi; Teresa Guimaraes; Adriana Porta; Irene K Miura; Cristian Borges; Helry Candido; Marcel Benavides; Flavia H Feier; Andre Godoy; Rita Antonelli Cardoso; Mario Kondo; Paulo Chapchap; Joao Seda Neto
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

5.  Regional variation and use of exception letters for cadaveric liver allocation in children with chronic liver disease.

Authors:  Paolo R Salvalaggio; Katie Neighbors; Susan Kelly; Karan M Emerick; Kishore Iyer; Riccardo A Superina; Peter F Whitington; Estella M Alonso
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

6.  MELD Exceptions and Rates of Waiting List Outcomes.

Authors:  A B Massie; B Caffo; S E Gentry; E C Hall; D A Axelrod; K L Lentine; M A Schnitzler; A Gheorghian; P R Salvalaggio; D L Segev
Journal:  Am J Transplant       Date:  2011-09-15       Impact factor: 8.086

7.  National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).

Authors:  Benjamin L Shneider; Frederick J Suchy; Sukru Emre
Journal:  Liver Transpl       Date:  2006-01       Impact factor: 5.799

8.  Heterogeneity and disparities in the use of exception scores in pediatric liver allocation.

Authors:  E K Hsu; M Shaffer; M Bradford; N Mayer-Hamblett; S Horslen
Journal:  Am J Transplant       Date:  2015-02       Impact factor: 8.086

Review 9.  Improving liver allocation: MELD and PELD.

Authors:  Richard B Freeman; Russell H Wiesner; John P Roberts; Suzanne McDiarmid; Dawn M Dykstra; Robert M Merion
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

10.  United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.

Authors:  Robert G Gish; Robert J Wong; Gordon Honerkamp-Smith; Ronghui Xu; Robert W Osorio
Journal:  Clin Transplant       Date:  2015-04-16       Impact factor: 2.863

View more
  13 in total

1.  Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.

Authors:  Emily R Perito; John Bucuvalas; Jennifer C Lai
Journal:  Am J Transplant       Date:  2018-12-31       Impact factor: 8.086

2.  Justifying Nonstandard Exception Requests for Pediatric Liver Transplant Candidates: An Analysis of Narratives Submitted to the United Network for Organ Sharing, 2009-2014.

Authors:  E R Perito; H J Braun; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2017-02-28       Impact factor: 8.086

3.  Competing risks and the risks of children and adults competing for livers.

Authors:  Paul A MacLennan; Babak J Orandi
Journal:  Am J Transplant       Date:  2020-07-25       Impact factor: 8.086

4.  Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data.

Authors:  Sharad Indur Wadhwani; Evelyn K Hsu; Michele L Shaffer; Ravinder Anand; Vicky Lee Ng; John C Bucuvalas
Journal:  Pediatr Transplant       Date:  2019-07-22

5.  Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database.

Authors:  Noelle H Ebel; Evelyn K Hsu; Kristin Berry; Simon P Horslen; George N Ioannou
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

6.  The Impact of Increased Allocation Priority for Children Awaiting Liver Transplant: A Liver Simulated Allocation Model (LSAM) Analysis.

Authors:  Emily R Perito; Douglas B Mogul; Douglas VanDerwerken; George Mazariegos; John Bucuvalas; Linda Book; Simon Horslen; Heung B Kim; Tamir Miloh; Vicky Ng; Jorge Reyes; Manuel I Rodriguez-Davalos; Pamela L Valentino; Sommer Gentry; Evelyn Hsu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-04       Impact factor: 2.839

7.  Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.

Authors:  Sonja M Swenson; John P Roberts; Sue Rhee; Emily R Perito
Journal:  Am J Transplant       Date:  2019-09-03       Impact factor: 8.086

8.  Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.

Authors:  Chung-Chou H Chang; Cindy L Bryce; Benjamin L Shneider; Jonathan G Yabes; Yi Ren; Gabriel L Zenarosa; Heather Tomko; Drew M Donnell; Robert H Squires; Mark S Roberts
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

9.  Determinants of length of stay after pediatric liver transplantation.

Authors:  Karina Covarrubias; Xun Luo; Allan Massie; Kathleen B Schwarz; Jacqueline Garonzik-Wang; Dorry L Segev; Douglas B Mogul
Journal:  Pediatr Transplant       Date:  2020-03-25

10.  Neighborhood socioeconomic deprivation, racial segregation, and organ donation across 5 states.

Authors:  Sharad I Wadhwani; Cole Brokamp; Erika Rasnick; John C Bucuvalas; Jennifer C Lai; Andrew F Beck
Journal:  Am J Transplant       Date:  2020-08-04       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.